Načítá se...
Ripretinib for the treatment of advanced gastrointestinal stromal tumor
Gastrointestinal stromal tumors (GISTs) are rare tumors of the gastrointestinal (GI) tract yet represent the most common GI sarcomas. Most GISTs are driven by activating mutations of the KIT and/or PDGFRA genes. Prior to the development of tyrosine kinase inhibitors (TKIs), GISTs were associated wit...
Uloženo v:
| Vydáno v: | Therap Adv Gastroenterol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053826/ https://ncbi.nlm.nih.gov/pubmed/33948116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562848211008177 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|